Crossmark

Targeted next generation sequencing provides insight for the genetic alterations in liquid biopsy of Egyptian brain tumor patients

Published Online: 2022-02-23

Published Print: 2022-12

Authors

Kassem, Neemat M. http://orcid.org/0000-0001-9295-2823
Kassem, Hebatallah A. http://orcid.org/0000-0002-6033-6839
Selim, Hanan

Hafez, Mohamed
License Information

Text and Data Mining valid from 2022-02-23

Version of Record valid from 2022-02-23
More Information

Article History

Received: 22 April 2021

Accepted: 6 November 2021

First Online: 23 February 2022

Declarations

:

: The study was accepted by Kasr Al Ainy Clinical Oncology department Institutional Review Board (IRB)-11-2019. Informed consent in a written form was taken from all patients involved in this work.

: This consent was obtained from all patients involved in this work.

: No conflict of interest has been declared.

Document is current